Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.

PURPOSE Determination of the underlying etiology of left ventricular hypertrophy (LVH) is a common, challenging, and critical clinical problem. The authors aimed to test whether pathological LVH, such as occurs in hypertrophic cardiomyopathy (HCM), hypertensive heart disease, or aortic stenosis, and physiological LVH in athletes, can be distinguished by means of left ventricular volume and geometric indices, derived from cardiovascular magnetic resonance imaging. METHODS A total of 120 subjects were studied on a 1.5 Tesla MR (Sonata, Siemens Medical Solutions, Erlangen, Germany) scanner, comprising healthy volunteers (18), competitive athletes (25), patients with HCM (35), aortic stenosis (24), and hypertensive heart disease (18). Left ventricular mass index, ejection fraction, end-diastolic, end-systolic and stroke volume index, diastolic wall thickness, wall thickness ratio and diastolic and systolic wall-to-volume ratios were determined. RESULTS Left ventricular (LV) mass indices were similar for all forms of LVH (p > 0.05), which were at least 35% higher than those obtained in healthy volunteers (p < 0.05). Multiple logistic regression showed that the percentage of correctly predicted diagnoses was 100% for athlete's heart, 80% for hypertrophic cardiomyopathy, 54% for aortic stenosis, and 22% for hypertensive heart disease. Using a receiver operating curve-determined cut-off value for diastolic wall-to-volume ratio of less than 0.15 mm x m2 x ml(-1), athletes' hearts could be differentiated from all forms of pathological cardiac hypertrophy with 99% specificity. CONCLUSIONS Athlete's heart can be reliably distinguished from all forms of pathological cardiac hypertrophy using CMR-derived LV volume and geometric indices, but pathological forms of LVH present with overlapping cardiac hypertrophy phenotypes. This capability of CMR should be of high clinical value.

[1]  E. Olson,et al.  Decoding calcium signals involved in cardiac growth and function , 2000, Nature Medicine.

[2]  A. Devlin,et al.  Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of gene carriage in familial disease: a simple echocardiographic procedure , 2000, Journal of medical screening.

[3]  H. Watkins,et al.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. , 2003, Trends in genetics : TIG.

[4]  W. Roberts,et al.  Causes of sudden death in competitive athletes. , 1986, Journal of the American College of Cardiology.

[5]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[6]  B. Maron,et al.  Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning , 2002, Circulation.

[7]  C. Tracy,et al.  American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, European heart journal.

[8]  D J Pennell,et al.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? , 2000, European heart journal.

[9]  I. Ostman-Smith.  Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. , 1981, Clinical science.

[10]  B. Maron,et al.  Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. , 1993, British heart journal.

[11]  C. Oakley,et al.  M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. , 1980, The American journal of cardiology.

[12]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[13]  L. T. Sheffield,et al.  Interventricular Septal Thickness and Left Ventricular Hypertrophy: An Echocardiographic Study , 1979, Circulation.

[14]  A. Pelliccia,et al.  Physiologic Left Ventricular Cavity Dilatation in Elite Athletes , 1999, Annals of Internal Medicine.

[15]  W. Mckenna,et al.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. , 2000, The American journal of cardiology.

[16]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[17]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[18]  A. Devlin,et al.  A simple method for assessing the regression or progression of ventricular hypertrophy in the growing child and adult: the value of left ventricular wall-to-cavity ratios. , 2001, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[19]  I. Östman-Smith.  Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. , 1981 .

[20]  Dudley J Pennell,et al.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[21]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[22]  W. Henry,et al.  Comparative left ventricular dimensions in trained athletes. , 1975, Annals of internal medicine.

[23]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[24]  W. Mckenna,et al.  The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience , 2004, European Journal of Applied Physiology.

[25]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[26]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[27]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[28]  L. McLain,et al.  Sudden death in young athletes. , 2003, Pediatric annals.

[29]  E. Coyle,et al.  Effects of physical deconditioning after intense endurance training on left ventricular dimensions and stroke volume. , 1986, Journal of the American College of Cardiology.

[30]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[31]  Jian Xu,et al.  Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy , 2004, Circulation research.

[32]  P. Kang,et al.  Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A H Zwinderman,et al.  The athlete's heart. A meta-analysis of cardiac structure and function. , 2000, Circulation.